I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Guidi, Lorenzo
315
results:
Search for persons
X
Format
Online (315)
Mediatypes
Articles (Online) (120)
Bookchapter (Online) (9)
OpenAccess-fulltext (185)
Thesis (Online) (1)
Languages
english (279)
more...
italian (5)
spanish (2)
less...
Sorted by: Year
Sorted by: Relevance
?
1
Immunotherapy in the neoadjuvant treatment of gastrointesti..:
Gervaso, Lorenzo
;
Ciardiello, Davide
;
Oliveira, Rivadavio Antunes
...
Journal for ImmunoTherapy of Cancer. 12 (2024) 5 - p. e008027 , 2024
Link:
https://doi.org/10.1136/..
?
2
Case report: complete long-lasting response to multimodal t..:
Castelli, Barbara
;
Tellini, Marco
;
Guidi, Melina
...
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
LGG-45. LOW DOSE CARBOPLATIN – ETOPOSIDE REGIMEN IN PEDIATR..:
Tellini, Marco
;
Nicola, Marco Di
;
Fonte, Carla
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
4
HGG-34. EFFICACY AND SAFETY OF DOXORUBICIN PLUS STANDARD TH..:
Castelli, Barbara
;
Tellini, Marco
;
Fonte, Carla
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
5
Circulating tumor DNA in patients with locally advanced rec..:
Gervaso, Lorenzo
;
Ciardiello, Davide
;
Gregato, Giuliana
...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
6
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negat..:
Cantini, Luca
;
Trapani, Dario
;
Guidi, Lorenzo
...
Cancer Treatment Reviews. 123 (2024) - p. 102669 , 2024
Link:
https://doi.org/10.1016/..
?
7
Biomimetic Approaches in Scaffold-Based Blood Vessel Tissue..:
Rosellini, Elisabetta
;
Giordano, Cristiana
;
Guidi, Lorenzo
.
Biomimetics. 9 (2024) 7 - p. 377 , 2024
Link:
https://doi.org/10.3390/..
?
8
OTHR-05. ROLES OF GEMCITABINE-OXALIPLATIN (GEMOX) ADD-ON TH..:
Castelli, Barbara
;
Fonte, Carla
;
Guidi, MIlena
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
9
Light-responsive polymeric nanoparticles for retinal drug d..:
Guidi, Lorenzo
;
Cascone, Maria Grazia
;
Rosellini, Elisabetta
Heliyon. 10 (2024) 5 - p. e26616 , 2024
Link:
https://doi.org/10.1016/..
?
10
The evolving landscape of metastatic HER2-positive, hormone..:
Boscolo Bielo, Luca
;
Trapani, Dario
;
Nicolò, Eleonora
...
Cancer Treatment Reviews. 128 (2024) - p. 102761 , 2024
Link:
https://doi.org/10.1016/..
?
11
Corrigendum to "Cognitive performance at first episode of p..:
Millgate, Edward
;
Smart, Sophie E.
;
Pardiñas, Antonio F.
...
Schizophrenia Research. 270 (2024) - p. 495-496 , 2024
Link:
https://doi.org/10.1016/..
?
12
MDB-51. PHASE II INTERVENTIONAL STUDY TO EVALUATE THE SAFET..:
Guidi, Milena
;
Fonte, Carla
;
Tellini, Marco
...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024
Link:
https://doi.org/10.1093/..
?
13
Corrigendum: Bevacizumab-Irinotecan combination therapy in ..:
Castelli, Barbara
;
Fonte, Carla
;
Guidi, Milena
...
Frontiers in Oncology. 14 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
14
Presentation_1_Bevacizumab-Irinotecan combination therapy i..:
Barbara Castelli
;
Carla Fonte
;
Milena Guidi
...
doi:10.3389/fonc.2023.1244628.s001. , 2024
Link:
https://doi.org/10.3389/..
?
15
Presentation_1_Bevacizumab-Irinotecan combination therapy i..:
Barbara Castelli
;
Carla Fonte
;
Milena Guidi
...
doi:10.3389/fonc.2023.1244628.s001. , 2024
Link:
https://doi.org/10.3389/..
1-15